Previous studies have also suggested that IL6/STAT3 signaling was a promising target for treating liver fibrosis (Deng et al., 2013; Su et al., 2015; Xiang et al., 2018; Marti-Rodrigo et al., 2020). The gene discussed is IL6; the disease is Hepatic fibrosis.